Cencora Enhances Global Pharmaceutical Logistics Services, Cold Chain Capabilities

About this update from Cencora, Inc.

[{"type":"text","content":"Expanded capabilities in Europe and the United States enable company to deliver enhanced third-party logistics support to pharmaceutical companies","length":146,"tagName":"p","attribs":{}},{"type":"text","content":"CONSHOHOCKEN, Pa., December 03, 2025--(BUSINESS WIRE)--Cencora, a global pharmaceutical solutions company, today announced investments to enhance its third-party logistics (3PL) capabilities in the United States and Europe, expanding its global network and strengthening the specialty logistics services it can deliver to pharmaceutical companies worldwide.","length":357,"tagName":"p"},{"type":"text","content":"As more specialty pharmaceuticals reach the market and the demand for comprehensive drug supply management continues to increase, Cencora is enhancing its global 3PL services offering by:","length":187,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Increasing capabilities in key markets in Europe: Cencora is expanding its pan-European logistics capabilities through the addition of NextPharma Logistics, a healthcare logistics provider that delivers services across Germany, Austria and Switzerland. Cencora also will open a 3PL facility in Italy in 2026, building on recent investments to expand storage capacity in France, Spain and the UK.","length":395,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Expanding storage capacity, cold chain capabilities in the United States: Cencora plans to open a new, highly automated 500,000 square-foot 3PL facility in Texas in 2028.","length":170,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":565,"olType":false},{"type":"text","content":""Our customers trust us to serve as an extension of their operations. We continue to strengthen our pharmaceutical logistics capabilities through investments across our 3PL network to deliver enhanced support tailored to their needs," said Chris Williams, Senior Vice President and President of Alloga Europe & ICS. "Whether it’s a large-scale global program or supporting the launch of an advanced therapy in a new market, we’re able to provide the integrated support our customers need to navigate supply chain complexities, maximize commercial success and ensure efficient and reliable access to their products."","length":639,"tagName":"p"},{"type":"text","co...

More updates from Cencora, Inc.